What is Tegison used for?

Tegison is indicated for Psoriasis.

What development phase is Tegison in?

Tegison is FDA-approved (marketed).

What is the generic name of Tegison?

ETRETINATE is the generic (nonproprietary) name of Tegison.

Last reviewed 2026-04-20 · How we verify

Tegison (ETRETINATE)

FDA-approved withdrawn Small molecule Quality 31/100

At a glance

Generic name	ETRETINATE
Drug class	Retinoid
Target	Retinoic acid receptor RXR-gamma
Modality	Small molecule
Therapeutic area	Immunology
Phase	FDA-approved
First approval	1986

Approved indications

Psoriasis

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Tegison CI brief — competitive landscape report
Tegison updates RSS · CI watch RSS